The ‘CASCADE’ Network consists of the following organizational units: one Network Coordinating Center (supported via RFA-CA-21-045), three Research Bases (supported via RFA-CA-21-046), and eight Clinical Sites (three sites supported via RFA-CA-21-047; five additional sites to be supported via RFA-CA-22-051 in 2023).
|Organizational Unit||Principal Investigator(s)||Institution(s)||Grant No.|
|CASCADE Network Coordinating Center (CNCC)||Suzanne Siminski, M.S., M.B.A., KyungMann Kim, Ph.D., and Anna-Barbara Moscicki, M.D.||Frontier Science, with
University of Wisconsin and
University of California, Los Angeles
|Research Base 1 (RB1)||Rachel Winer, Ph.D., M.P.H. and
Elizabeth Brown, Sc.D., M.S.
|University of Washington, with
Fred Hutchinson Cancer Research Center
|Research Base 2 (RB2)||Timothy Wilkin, M.D., M.P.H., Anna Giuliano, Ph.D., and
Carla Chibwesha, M.D., M.Sc.
|Weill Medical College of Cornell University, with Moffitt Cancer Center and University of North Carolina at Chapel Hill||UG1CA275414|
|Research Base 3 (RB3)||Jennifer Smith, Ph.D., M.P.H., Michael Hudgens, Ph.D., and Lameck Chinula, M.D., M.P.H.||University of North Carolina at Chapel Hill||UG1CA275403|
|Clinical Trials Site 1 (CS1): Uganda||Betty Mwesigwa, M.B.Ch.B., M.Sc.||Makerere University Walter Reed Project, with US Military HIV Research Program and Uganda Cancer Institute||UG1CA275412|
|Clinical Trials Site 2 (CS2): Kenya||Michael Chung, M.D., Ph.D., M.P.H. and Samah Sakr, M.B.Ch.B.||Emory University, with Coptic Hope Center for Infectious Diseases and Kenyatta National Hospital||UG1CA275400|
|Clinical Trials Site 3 (CS3): Botswana||Scott Dryden-Peterson, M.D., M.S. and Doreen Ramogola-Masire, M.B.B.S., Ph.D., M.P.H.||Brigham and Women's Hospital, with Botswana Harvard AIDS Institute Partnership||UG1CA275416|